Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

The combination treatment showed a higher response rate but no significant survival benefits.

Using 5% minoxidil foam twice daily can help regrow hair, especially in younger men aged 20-30.

Reconstructed skin models are useful for studying how skin processes certain chemicals.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Topical finasteride is a safe and effective treatment for pattern hair loss with fewer side effects than oral finasteride.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Mint water extract boosts protective enzymes in skin cells.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Docetaxel is effective against various cancers but mainly causes neutropenia.